Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting
- PMID: 22961023
- DOI: 10.1086/667733
Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting
Abstract
Objective: To describe the epidemiology and healthcare costs of Clostridium difficile infection (CDI) identified in the outpatient setting.
Design: Population-based, retrospective cohort study.
Patients: Kaiser Permanente Colorado and Kaiser Permanente Northwest members between June 1, 2005, and September 30, 2008.
Methods: We identified persons with incident CDI and classified CDI by whether it was identified in the outpatient or inpatient healthcare setting. We collected information about baseline variables and follow-up healthcare utilization, costs, and outcomes among patients with CDI. We compared characteristics of patients with CDI identified in the outpatient versus inpatient setting.
Results: We identified 3,067 incident CDIs; 56% were identified in the outpatient setting. Few strong, independent predictors of diagnostic setting were identified, although a previous stay in a nonacute healthcare institution (odds ratio [OR], 1.45 [95% confidence interval (CI), 1.13-1.86]) was statistically associated with outpatient-identified CDI, as was age from 50 to 59 years (OR, 1.64 [95% CI, 1.18-2.29]), 60 to 69 years (OR, 1.37 [95% CI, 1.03-1.82]), and 70 to 79 years (OR, 1.36 [95% CI, 1.06-1.74]), when compared with persons aged 80-89 years.
Conclusions: We found that more than one-half of incident CDIs in this population were identified in the outpatient setting. Patients with outpatient-identified CDI were younger with fewer comorbidities, although they frequently had previous exposure to healthcare. These data suggest that practitioners should be aware of CDI and obtain appropriate diagnostic testing on outpatients with CDI symptoms.
Similar articles
-
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056. JAMA Intern Med. 2013. PMID: 23780507
-
Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score.Clin Microbiol Infect. 2015 Mar;21(3):256-62. doi: 10.1016/j.cmi.2014.11.001. Epub 2014 Nov 11. Clin Microbiol Infect. 2015. PMID: 25658533
-
A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure.Infect Control Hosp Epidemiol. 2015 Dec;36(12):1409-16. doi: 10.1017/ice.2015.220. Epub 2015 Sep 21. Infect Control Hosp Epidemiol. 2015. PMID: 26387888
-
Economic healthcare costs of Clostridium difficile infection: a systematic review.J Hosp Infect. 2010 Apr;74(4):309-18. doi: 10.1016/j.jhin.2009.10.016. Epub 2010 Feb 12. J Hosp Infect. 2010. PMID: 20153547 Review.
-
The economic impact of Clostridium difficile infection: a systematic review.Am J Gastroenterol. 2015 Apr;110(4):511-9. doi: 10.1038/ajg.2015.48. Epub 2015 Apr 7. Am J Gastroenterol. 2015. PMID: 25848925 Review.
Cited by
-
Economic Burden of Clostridioides difficile Infection in European Countries.Adv Exp Med Biol. 2024;1435:1-12. doi: 10.1007/978-3-031-42108-2_1. Adv Exp Med Biol. 2024. PMID: 38175468
-
Clostridium difficile infection in pediatric patients (Review).Biomed Rep. 2023 Dec 8;20(2):18. doi: 10.3892/br.2023.1706. eCollection 2024 Feb. Biomed Rep. 2023. PMID: 38169799 Free PMC article. Review.
-
Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset.Clin Infect Dis. 2023 Mar 4;76(5):809-815. doi: 10.1093/cid/ciac841. Clin Infect Dis. 2023. PMID: 36285546 Free PMC article.
-
Resources Assessment for Penicillin Allergy Testing Performed by Pharmacists at the Patient's Bedside.Ann Pharmacother. 2021 Nov;55(11):1355-1362. doi: 10.1177/10600280211002412. Epub 2021 Mar 11. Ann Pharmacother. 2021. PMID: 33703922 Free PMC article.
-
Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving Antibiotics.Open Forum Infect Dis. 2017 Jul 22;4(3):ofx148. doi: 10.1093/ofid/ofx148. eCollection 2017 Summer. Open Forum Infect Dis. 2017. PMID: 29230429 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
